- Home
- TTNP vs VERO Comparison
TTNP vs VERO Comparison
Compare TTNP & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- VERO
- Stock Information
- Founded
- TTNP 1991
- VERO N/A
- Country
- TTNP United States
- VERO Canada
- Employees
- TTNP N/A
- VERO N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- VERO Medical/Dental Instruments
- Sector
- TTNP Health Care
- VERO Health Care
- Exchange
- TTNP Nasdaq
- VERO Nasdaq
- Market Cap
- TTNP 3.0M
- VERO 2.4M
- IPO Year
- TTNP 1996
- VERO N/A
- Fundamental
- Price
- TTNP $3.67
- VERO $0.31
- Analyst Decision
- TTNP
- VERO
- Analyst Count
- TTNP 0
- VERO 0
- Target Price
- TTNP N/A
- VERO N/A
- AVG Volume (30 Days)
- TTNP 25.0K
- VERO 128.1K
- Earning Date
- TTNP 03-31-2025
- VERO 03-31-2025
- Dividend Yield
- TTNP N/A
- VERO N/A
- EPS Growth
- TTNP N/A
- VERO N/A
- EPS
- TTNP N/A
- VERO N/A
- Revenue
- TTNP N/A
- VERO $67,200,000.00
- Revenue This Year
- TTNP N/A
- VERO N/A
- Revenue Next Year
- TTNP N/A
- VERO $4.95
- P/E Ratio
- TTNP N/A
- VERO N/A
- Revenue Growth
- TTNP N/A
- VERO N/A
- 52 Week Low
- TTNP $3.03
- VERO $0.28
- 52 Week High
- TTNP $14.80
- VERO $1.59
- Technical
- Relative Strength Index (RSI)
- TTNP 50.98
- VERO 38.70
- Support Level
- TTNP $3.35
- VERO $0.30
- Resistance Level
- TTNP $4.24
- VERO $0.32
- Average True Range (ATR)
- TTNP 0.29
- VERO 0.02
- MACD
- TTNP 0.02
- VERO -0.00
- Stochastic Oscillator
- TTNP 46.73
- VERO 12.62
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.